Oncology

A study on lung cancer treatment shows that combining photodynamic therapy (PDT) with cisplatin significantly inhibits tumor growth, promoting apoptosis in lung adenocarcinoma cells.

Elevated salivary microvesicles are linked to non-healing oral ulcers and oral cancer, potentially aiding in early diagnosis.

The MITO 40 study, presented at ESGO 2025, highlights promising results for Niraparib as a maintenance treatment in ovarian cancer patients with no residual disease post-surgery.

Rucaparib showed longer progression-free survival, chemotherapy-free interval, and time to first subsequent treatment in advanced ovarian cancer patients, according to updated results from the ATHENA-MONO study.

ESGO 2025 study reveals overestimation of preoperative tumour size in stage IB2 cervical cancer, influencing adjuvant therapy decisions.

At the 2025 ESGO Annual Meeting, researchers unveiled two new diagnostic indices “Vienna Index” and “Top Vienna Index” which combine age with existing ovarian cancer biomarkers, significantly improving detection accuracy.

Study reveals a protein model to predict cardiomyopathy in childhood cancer survivors, enhancing early detection and intervention.

Aspirin was well-tolerated but did not significantly improve disease-free survival in high-risk colorectal cancer patients.